- Home
- EVTV vs KTTA Comparison
EVTV vs KTTA Comparison
Compare EVTV & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVTV
- KTTA
- Stock Information
- Founded
- EVTV 2012
- KTTA 2020
- Country
- EVTV United States
- KTTA United States
- Employees
- EVTV N/A
- KTTA N/A
- Industry
- EVTV Auto Manufacturing
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- EVTV Consumer Discretionary
- KTTA Health Care
- Exchange
- EVTV Nasdaq
- KTTA Nasdaq
- Market Cap
- EVTV 5.2M
- KTTA 5.7M
- IPO Year
- EVTV 2017
- KTTA 2021
- Fundamental
- Price
- EVTV $1.15
- KTTA $0.71
- Analyst Decision
- EVTV
- KTTA
- Analyst Count
- EVTV 0
- KTTA 0
- Target Price
- EVTV N/A
- KTTA N/A
- AVG Volume (30 Days)
- EVTV 94.6K
- KTTA 91.7K
- Earning Date
- EVTV 11-14-2025
- KTTA 11-13-2025
- Dividend Yield
- EVTV N/A
- KTTA N/A
- EPS Growth
- EVTV N/A
- KTTA N/A
- EPS
- EVTV N/A
- KTTA N/A
- Revenue
- EVTV $1,884,395.00
- KTTA N/A
- Revenue This Year
- EVTV N/A
- KTTA N/A
- Revenue Next Year
- EVTV N/A
- KTTA N/A
- P/E Ratio
- EVTV N/A
- KTTA N/A
- Revenue Growth
- EVTV 2.97
- KTTA N/A
- 52 Week Low
- EVTV $1.10
- KTTA $0.65
- 52 Week High
- EVTV $18.32
- KTTA $3.85
- Technical
- Relative Strength Index (RSI)
- EVTV 33.89
- KTTA 46.01
- Support Level
- EVTV $1.10
- KTTA $0.69
- Resistance Level
- EVTV $1.38
- KTTA $0.75
- Average True Range (ATR)
- EVTV 0.13
- KTTA 0.06
- MACD
- EVTV -0.02
- KTTA -0.01
- Stochastic Oscillator
- EVTV 8.20
- KTTA 33.98
About EVTV Envirotech Vehicles Inc.
Envirotech Vehicles Inc is a provider of purpose-built zero-emission electric vehicles focused on reducing the total cost of vehicle ownership and helping fleet operators unlock the benefits of green technology. It recognizes revenue from the sales of zero-emission electric vehicles and vehicle maintenance and inspection services. The Company serves commercial and last-mile fleets, school districts, public and private transportation service companies and colleges and universities to meet the increasing demand for light to heavy-duty electric vehicles.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).